These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22200632)

  • 1. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ; Chen CQ; Zhao ZM; Sun W
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo].
    Fan YZ; Zhao ZM; Fu JY; Chen CQ
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):618-22. PubMed ID: 16784656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect.
    Chen YJ; Tsai YM; Kuo CD; Ku KL; Shie HS; Liao HF
    Life Sci; 2009 Oct; 85(17-18):642-51. PubMed ID: 19765597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norcantharidin anti-angiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer.
    Yu T; Hou F; Liu M; Zhou L; Li D; Liu J; Fan Z; Li Q
    Asian Pac J Cancer Prev; 2012; 13(2):499-503. PubMed ID: 22524814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
    Wang H; Sun W; Zhang WZ; Ge CY; Zhang JT; Liu ZY; Fan YZ
    PLoS One; 2014; 9(5):e96982. PubMed ID: 24811250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
    Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
    Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.
    M HR; Ghosh D; Banerjee R; Salimath BP
    Pharm Biol; 2017 Dec; 55(1):1489-1499. PubMed ID: 28367666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism].
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):271-4. PubMed ID: 15312360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
    Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
    Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
    Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo.
    Yan S; Zhang H; Xie Y; Sheng W; Xiang J; Ye Z; Chen W; Yang J
    Cancer Invest; 2010 Jan; 28(1):85-93. PubMed ID: 19916746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
    Shen FZ; Wang J; Liang J; Mu K; Hou JY; Wang YT
    Int J Exp Pathol; 2010 Feb; 91(1):10-6. PubMed ID: 20096070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
    Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
    Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.